UK markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,651.00+11.50 (+0.70%)
At close: 04:35PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 66.99B
Enterprise value 80.02B
Trailing P/E 13.67
Forward P/E 10.44
PEG ratio (5-yr expected) 1.10
Price/sales (ttm)2.22
Price/book (mrq)5.02
Enterprise value/revenue 2.64
Enterprise value/EBITDA 8.81

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 39.29%
S&P500 52-week change 323.06%
52-week high 31,725.81
52-week low 31,302.60
50-day moving average 31,659.90
200-day moving average 31,508.11

Share statistics

Avg vol (3-month) 38.95M
Avg vol (10-day) 36.89M
Shares outstanding 54.09B
Implied shares outstanding 64.09B
Float 83.91B
% held by insiders 11.71%
% held by institutions 145.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.64
Forward annual dividend yield 43.90%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 30.04%
5-year average dividend yield 44.98
Payout ratio 446.50%
Dividend date 3N/A
Ex-dividend date 422 Feb 2024
Last split factor 24:5
Last split date 319 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 16.25%
Operating margin (ttm)20.35%

Management effectiveness

Return on assets (ttm)8.81%
Return on equity (ttm)46.38%

Income statement

Revenue (ttm)30.33B
Revenue per share (ttm)7.49
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
EBITDA 10.3B
Net income avi to common (ttm)4.93B
Diluted EPS (ttm)1.20
Quarterly earnings growth (yoy)-76.60%

Balance sheet

Total cash (mrq)5.69B
Total cash per share (mrq)1.4
Total debt (mrq)18.02B
Total debt/equity (mrq)140.82%
Current ratio (mrq)0.88
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)6.77B
Levered free cash flow (ttm)3.56B